<DOC>
	<DOC>NCT00704574</DOC>
	<brief_summary>This observational study is conducted in Europe. The trial aims to observe the incidence of serious adverse drug reactions in children and adolescents with type 1 diabetes during Levemir® treatment.</brief_summary>
	<brief_title>Observational Study to Observe the Safety of Levemir® Treatment in Children and Adolescents With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Informed consent obtained prior to any trialrelated activities Any patient with diabetes type 1 is eligible for the study, including newly The selection of the patients will be at the discretion of the individual physician Type 2 diabetes Currently treated with Levemir®</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>